Antioxidant and antiglycation properties of triterpenoid saponins from Aralia taibaiensis traditionally used for treating diabetes mellitus

Redox Report

Volumn 15, Issue 1, 2010, Pages 20-28

  Xi, Miaomiao ^a   Hai, Chunxu ^b   Tang, Haifeng ^a   Wen, Aidong ^a   Chen, Hongli ^b   Liu, Rui ^b   Liang, Xin ^b   Chen, Mingsheng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antidiabetes; Antiglycation; Antioxidant; Aralia taibaiensis; Free radical scavenger; Triterpenoid saponins

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 28 O BETA DEXTRO GLUCURONOPYRANOSYL ESTER; 3 O [ALPHA ARABINOFURANOSYL(1-4)BETA DEXTRO GLUCURONOPYRANOSYL]OLEANOLIC ACID; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-2)][ALPHA ARABINOFURANOSYL(1-3)]BETA DEXTRO GLUCURONOPYRANOSYL OLEANOLIC ACID; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-2)][BETA DEXTRO GLUCURONOPYRANOSYL(1-3)]ALPHA LEVO ARABINOPYRANOSYL OLEANOLIC ACID 28 O BETA DEXTRO GLUCOPYRANOSYL ESTER; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-2)][BETA DEXTRO GLUCURONOPYRANOSYL(1-3)]BETA DEXTRO GLUCOPYRANOSYL OLEANOLIC ACID 28 O BETA DEXTRO GLUCOPYRANOSYL ESTER; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-2)][BETA DEXTRO GLUCURONOPYRANOSYL]OLEAN 11,13(18) DIENE 28 OIC ACID 28 O BETA DEXTRO GLUCOPYRANOSYL ESTER; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-3)][ALPHA ARABINOFURANOSYL(1-4)]BETA DEXTRO GLUCURONOPYRANOSYL OLEANOLIC ACID; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-3)][ALPHA ARABINOFURANOSYL(1-4)]BETA DEXTRO GLUCURONOPYRANOSYL OLEANOLIC ACID 28 O BETA DEXTRO GLUCYROPYRANOSYL ESTER; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-3)][BETA DEXTRO GLUCURONOPYRANOSYL]OLEAN 11,13(18) DIENE 28 OIC ACID 28 O BETA DEXTRO GLUCOPYRANOSYL ESTER; 3 O [BETA DEXTRO GLUCOPYRANOSYL(1-4)][ BETA DEXTRO GLUCURONOPYRANOSYL]OLEANOLIC ACID 28 O BETA DEXTRO GLUCOPYRANOSYL ESTER; 3 O [BETA DEXTRO XYLOOPYRANOSYL(1-2)][BETA DEXTRO GLUCONOPYRANOSYL(1-3)]BETA DEXTRO GLUCURONOPYRANOSYL OLEANOIC ACID 28 O BETA DEXTRO GLUCOPYRANOSYL ESTER; 3 O BETA DEXTRO GLUCURONOPYRANOSYL OLEANOLIC ACID; ARALIA TAIBAIENSIS EXTRACT; ASCORBIC ACID; BOVINE SERUM ALBUMIN; CARBON TETRACHLORIDE; DELTA GLUCONOLACTONE; GLYCINE METHYL ESTER; HEMOGLOBIN; HYDROPEROXIDE; IRON; LACTONE; LIPID; PLANT EXTRACT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RIBOSE; SAPONIN; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARALIA; ARALIA TAIBAIENSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG STRUCTURE; ENZYME ASSAY; GEL PERMEATION CHROMATOGRAPHY; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INHIBITION KINETICS; LIPID PEROXIDATION; LIVER MICROSOME; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THIN LAYER CHROMATOGRAPHY;

ANIMALS; ANTIOXIDANTS; ARALIA; BIPHENYL COMPOUNDS; DRUG SYNERGISM; FREE RADICAL SCAVENGERS; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; MALE; MICROSOMES, LIVER; PICRATES; PLANT BARK; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SAPONINS; TRITERPENES;

ARALIA; BOVINAE; RATTUS;

EID: 77949476710     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/174329210X12650506623041     Document Type: Article

References (38)

1. Nawroth PP, Bierhaus A, Vogel GE et al. Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus. Med Klin 1999; 94: 29-38.
2. Vlassara H, Palace MR. Diabetes and advanced glycation endproducts. J Intern Med 2002; 251: 87-101.
3. McIntyre KL, Harris CS, Saleem A et al. Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium). Planta Med 2009; 75: 286-292.
4. Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 1991; 14: 68-72.
5. Duraisamy Y, Gaffney J, Slevin M, Smith CA, Williamson K, Ahmed N. Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine. Mol Cell Biochem 2003; 246: 143-153.
6. Xi M, Hai C, Tang H, Chen M, Fang K, Liang X. Antioxidant and antiglycation properties of total saponins extracted from traditional Chinese medicine used to treat diabetes mellitus. Phytother Res 2008; 22: 228-237.
7. Jia W, Gao W, Tang L. Antidiabetic herbal drugs officially approved in China. Phytother Res 2003; 17: 1127-1134.
8. Wu Z. Progress in the study of hypoglycemic action of the active constituents of Chinese herbal drugs and their therapy of type 2 diabetes mellitus. Zhongguo Zhong Yao Za Zhi 1998; 23: 118-120.
9. Zhang LH, Xiao PG. Recent advances in studies of antihyperlipaemic and antihyperglycaemic compounds from Chinese traditional and herbal medicines. Phytother Res 1993; 7: 217-226.
10. Yoshikawa M, Matsuda H. Antidiabetogenic activity of oleanolic acid glycosides from medicinal foodstuffs. Biofactors 2000; 13: 231-237.
11. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004; 92: 1-21.
12. Matsuda H, Murakami T, Shimada H, Matsumura N, Yoshikawa M, Yamahara J. Inhibitory mechanisms of oleanolic acid 3-Omonodesmosides on glucose absorption in rats. Biol Pharm Bull 1997; 20: 717-719.
13. Shimizu K, Ozeki M, Iino A, Nakajyo S, Urakawa N, Atsuchi M. Structure-activity relationships of triterpenoid derivatives extracted from Gymnema inodorum leaves on glucose absorption. Jpn J Pharmacol 2001; 86: 223-229.
14. Tang HF, Yi YH, Wang ZZ, Hu WJ, Li YQ. Studies on the triterpenoid saponins of the root bark of Aralia taibaiensis. Yao Xue Xue Bao 1996; 31: 517-523.
15. Tang HF, Yi YH, Wang ZZ, Jiang YP, Li YQ. Oleanolic acid saponins from the root bark of Aralia taibaiensis. Yao Xue Xue Bao 1997; 32: 685-690.
16. Hiai S, Oura H, Nakajima T. Color reaction of some sapogenins and saponins with vanillin sulphuric acid. Planta Med 1976; 29: 116-122.
17. Tang HF, Wang ZZ, Yi YH, Jiang YP, Hu WJ, Li YQ. Triterpenoid saponins from the root bark of Aralia taibaiensis. J Chin Pharm Sci 1997; 6: 75-81.
18. Satav JG, Katyare SS. Effect of experimental thyrotoxicosis on oxidative phosphorylation in rat liver, kidney and brain. Mol Cell Endocrinol 1982; 28: 178-189.
19. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
20. Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990; 15: 129-135.
21. Pompella A, Maellaro E, Casini A, Ferrali M, Ciccoli L, Comporti M. Measurement of lipid peroxidation in vivo: a comparison of different procedures. Lipids 1987; 22: 206-211.
22. Slater TF, Sawyer BC. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reaction in rat liver fractions in vitro. Biochem J 1971; 123: 805-814.
23. Yokozawa T, Chen CP, Dong E, Tanaka T, Nonaka GI, Nishioka I. Study on the inhibitory effect of tannins and flavonoids against DPPH radical. Biochem Pharmacol 1998; 56: 213-222.
24. Rahbar S, Nadler JL. A new rapid method to detect inhibition of Amadori product generated by δ-gluconolactone. Clin Chim Acta 1999; 287: 123-130.
25. Ikeda K, Higashi T, Sano H et al. N(epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 1996; 35: 8075-8083.
26. Nagaraj RH, Shipanova IN, Faust FM. Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J Biol Chem 1996; 271: 19338-19345.
27. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991; 10: 339-352.
28. Aruoma OI. Free radicals, oxidative stress, and antioxidants in human health and disease. J Am Oil Chem Soc 1998; 75: 199-212.
29. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
30. Vlassara H. Advanced glycation endproducts and atherosclerosis. Ann Med 1996; 28: 419-426.
31. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009; 46: 531-542.
32. Fogliano V, Verde V, Randazzo G, Ritieni X. A method for measuring antioxidant activity and its application to monitoring the antioxidant capacity of wines. J Agric Food Chem 1999; 47: 1035-1040.
33. Gao XQ, Ohlander M, Jeppsson N, Bjork L, Trajkovski V. Changes in antioxidant effects and their relationship to phytonutrients in fruits of Sea Buckthorn (Hippophae rhamnoides L.) during maturation. J Agric Food Chem 2000; 48: 1485-1490.
34. Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Rec Prog Horm Res 2001; 56: 1-21.
35. Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004; 53: 131-142.
36. Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001; 18: 685-716.
37. Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. Protective activity of green tea against free radical- and glucose-mediated protein damage. J Agric Food Chem 2002; 50: 2418-2422.
38. Khalifa RG, Baynes JW, Hudson BG. Amadorins: novel post- Amadori inhibitors of advanced glycation end product. Biochem Biophys Res Commun 1999; 257: 251-258.